|本期目录/Table of Contents|

[1]许玉黎,黄惠娟,谢树红,等.橄榄苦苷对卵巢癌裸鼠皮下移植瘤抑瘤作用的研究[J].医学研究与战创伤救治(原医学研究生学报),2018,20(06):561-565.[doi:10.3969/j.issn.1672-271X.2018.06.001]
　XU Yu-li,HUANG Hui-juan,XIE Shu-hong,et al.Study on antitumor effects of oleuropein on ovarian cancer subcutaneous transplanted tumor in nude mice[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(06):561-565.[doi:10.3969/j.issn.1672-271X.2018.06.001]
点击复制

橄榄苦苷对卵巢癌裸鼠皮下移植瘤抑瘤作用的研究()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第20卷
期数:
2018年06期
页码:
561-565
栏目:
基础研究
出版日期:
2018-11-20

文章信息/Info

Title:
Study on antitumor effects of oleuropein on ovarian cancer subcutaneous transplanted tumor in nude mice
作者:
许玉黎; 黄惠娟; 谢树红; 陈涣涣; 田黎明; 杨帆; 曾小娟
作者单位：350025福州，福建医科大学福总临床医学院(南京军区福州总医院) 妇产科（许玉黎、黄惠娟、谢树红、陈涣涣、曾小娟）；350025 福州，厦门大学附属东方医院妇产科（田黎明、杨帆）
Author(s):
XU Yu-li1; HUANG Hui-juan1; XIE Shu-hong1; CHEN Huan-huan1; TIAN Li-ming2; YANG Fan2; ZENG Xiao-juan1
(1. Department of Obestetrics and Gynecology，Clinical Medical School，Fuzhou General Hospital of Fujian Medical University/Fuzhou General Hospital of Nanjing Military Region, PLA，Fuzhou 350025，Fujian，China; 2. Department of Obstetrics and Gynecology，East Hospital Affiliated to Xiamen University，Fuzhou 350025，Fujian，China)
关键词:
橄榄苦苷; 卵巢癌; 移植瘤; 抑瘤
Keywords:
oleuropein;  ovarian cancer;  transplanted tumor;  tumor inhibition
分类号:
R711.7
DOI:
10.3969/j.issn.1672-271X.2018.06.001
文献标志码:
A
摘要:
目的 观察橄榄苦苷对卵巢癌SKOV3裸鼠皮下移植瘤生长的影响，探讨其作用机制。方法 建立卵巢癌SKOV3细胞裸鼠皮下移植瘤的模型，将20只荷瘤裸鼠随机分为2组，橄榄苦苷组：50mg/(kg·d)，按10mL/kg腹腔内注射；等渗盐水组：按0.9%氯化钠注射液10mL/kg腹腔内注射。2组均隔天给药1次，连续给药8周，自由摄水和进食，标准SPF饲养。每周测量裸鼠体重和肿瘤体积各1次。处死裸鼠后，完整分离出肿瘤组织，计算肿瘤的相对增殖率，采用Western blot法分别检测2组肿瘤组织促凋亡因子Bax、抗凋亡因子Bcl-2的表达水平。结果 橄榄苦苷组裸鼠在注射药物后21d、35d、56d的移植瘤体积明显小于等渗盐水组（P＜0.01）；橄榄苦苷组的相对肿瘤增殖率为70.3%；与等渗盐水组比较，橄榄苦苷组Bcl-2蛋白表达下调，而Bax蛋白表达上调。 结论 橄榄苦苷对卵巢癌SKOV3裸鼠皮下移植瘤的生长有抑制作用，机制可能与抑制抗凋亡因子Bcl-2的表达，增强凋亡促进因子Bax的表达有关。
Abstract:
Objective To observe the effects of oleuropein on the growth of subcutaneously transplanted ovarian cancer SKOV3 in nude mice and to explore its mechanism.Methods Established subcutaneous xenograft model of ovarian cancer SKOV3 cells. Twenty nude mice were randomly divided into two groups. Oleuropein group: 50 mg/(kg· d)，10 mL/kg intraperitoneally, saline group: 0.9 % sodium chloride injection 10 mL/kg intraperitoneal injection. Both groups were administered once every other day for 8 weeks, free water intake, and standard SPF feed. The tumor volume and body weight of nude mice were measured and recorded once a week. After the nude mice were sacrificed, the tumor tissues were completely isolated and the relative proliferation rate of the tumors was calculated. Western blot was utilized to detect the expression levels of pro-apoptosis factor Bax and anti-apoptosis factor Bcl-2 in the two groups of tumor tissues.Results The tumor volume of oleuropein group in nude mice at 21 days, 35 days and 56 days after injection was significantly smaller than that of saline group(P<0.01); the relative tumor proliferation rate of oleuropein group was 70.3%; compared with saline group, oleuropein group Bax protein expression was up-regulated while Bcl-2 protein expression was down-regulated.Conclusion Oleuropein inhibits the growth of ovarian cancer SKOV3 cells subcutaneous transplanted tumor in nude mice. The mechanism may be related to inhibiting the expression of anti-apoptosis factor Bcl-2 and enhancing the expression of apoptosis-promoting factor Bax.

参考文献/References:

[1]Siegel RL，Miller KD，Jemal A. Cancer statistics, 2017[J]. CA Cancer J Clin, 2017, 67(1):7-30.
[2］高梦颖，黄惠娟，谢树红.橄榄苦苷对破骨细胞增殖影响的实验研究[J]. 中国骨质疏松杂志，2017，23(7):896-899.
[3］Carrera-González MP, Ramírez-Expósito MJ, Mayas MD, et al. Protective role of oleuropein and its metabolite hydroxytyrosol on cancer[J]. Trends Food Sci Tech,2013,31(2):92-99.
[4］Kearns AE, Khosla S, Kostenuik PJ.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease[J]. Endocr Rev,2008,29(4):155-192.
[5］陈桂莲，黄惠娟，田黎明.橄榄苦甙对卵巢辐射损伤的防治效果[J]. 东南国防医药，2017，19(6):576-580.
[6］陈千良, 孙文基. 裂环烯醚萜类化合物研究进展[J].现代药物与临床，2003，18(2):58-63.
[7］Hamdi HK, Castellon R. Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor[J]. Biochem Biophys Res Commun, 2005, 334(3):769-778.
[8］Giner E,Recio MC,Rios JL,et al．Chemopreventive effect of oleuropein in colitis-associated colorectal cancer in c57bl/6 mice[J].Mol Nutr Food Res，2016,60(2):242-255．
[9］Bulotta S,Corradino R,Celano M,et al.Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells[J]. J Mol Endocrinol, 2013,51(1):181-189.
[10］Kimura Y, Sumiyoshi M. Olive leaf extract and its main component oleuropein prevent chronic ultraviolet B radiation-induced skin damage and carcinogenesis in hairless mice[J]. J Nutr, 2009, 139(11):2079-2086.
[11］关婷．细胞凋亡与卵巢肿瘤[J]．国外医学妇幼保健分册，2000，11(2)：54-56．
[12］王颖欣，韩萍，陈燕.Bcl-2蛋白和Bax蛋白在上皮性卵巢癌中的表达及临床意义[J].西部医学，2011，23(5)：814-816，819.
[13］Hassan ZK, Elamin MH, Omer SA, et al. Oleuropein induces apoptosis via the p53 pathway in breast cancer cells[J]. Asian Pac J Cancer Prev, 2013, 14(11):6739-6742.
[14］Liu M,Wang J,Huang B, et al. Oleuropein inhibits the proliferation and invasion of glioma cells via suppression of the AKT signaling pathway[J].Oncol Rep，2016,36(4):2009-2016.
[15］张晓霞，费军伟，高咏梅,等.磷脂酰肌醇3-激酶在卵巢癌中的表达[J].中国实用妇科与产科杂志，2008，24(11):851-852.
[16］Asati V, Mahapatra DK, Bharti SK. PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives[J]. Eur J Med Chem, 2016, 109(2):314-341.

相似文献/References:

[1]李彩云,龚谋春,潘建虎,等.卵巢癌二次探查手术前PET-CT检查的作用及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2013,15(02):141.
　.Department of Obstetrics and Gynecology.PET-CT Center7 Hospital of PLA,Hangzhou,Zhejiang 00,et al.LI Cai-yun1,GONG Mou-chun1,PAN Jian-hu2[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(06):141.
[2]孙 健,卢 健,邹冬芳,等.结肠腺瘤性息肉病基因异常甲基化在 上皮性卵巢癌中的检测及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2008,10(06):414.
　SUN Jian,LU Jian,ZOU Dong-fang,et al.Significance of hypermethylation of APC in epithelial ovarian carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2008,10(06):414.
[3]朱饮源,姚 军,李 曼.糖原合成酶激酶3β对卵巢癌紫杉醇耐药性的影响及机制研究[J].医学研究与战创伤救治(原医学研究生学报),2015,17(01):29.[doi:10.3969/j.issn.1672-271X.2015.01.009]
　ZHU Yin-yuan,YAO Jun,LI Man..The effects of GSK-3β on paclitaxel chemoresistance of ovarian cancer cells[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(06):29.[doi:10.3969/j.issn.1672-271X.2015.01.009]
[4]陈 慧,张 兰,郭以河,等.Eag1钾离子通道在卵巢癌组织中的表达及意义[J].医学研究与战创伤救治(原医学研究生学报),2016,18(01):17.[doi:10.3969/j.issn.1672-271X.2016.01.005]
　CHEN Hui,ZHANG Lan,GUO Yi-he,et al.Expression and significance ofether à go-go 1 channels in human ovarian cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(06):17.[doi:10.3969/j.issn.1672-271X.2016.01.005]
[5]赵昊云,张承,杨林东综述,等.卵巢癌的脑转移诊疗进展[J].医学研究与战创伤救治(原医学研究生学报),2016,18(02):180.[doi:10.3969/j.issn.1672-271X.2016.02.022]
[6]洪丽君,曾清芳,卢昆林,等.高尔基体磷蛋白3在卵巢癌中的表达及临床意义[J].医学研究与战创伤救治(原医学研究生学报),2017,19(04):357.[doi:10.3969/j.issn.1672-271X.2017.04.006]
　HONG Li-jun,ZENG Qing-fang,LU Kun-lin,et al.Expression and clinical significance of Golgi phosphoprotein 3 in ovarian cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2017,19(06):357.[doi:10.3969/j.issn.1672-271X.2017.04.006]
[7]杨帆,谢树红综述,黄惠娟审校.卵巢癌在代谢组学中的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2018,20(02):160.[doi:10.3969/j.issn.1672-271X.2018.02.012]
[8]陈娟,刘传丽,陈艳思,等.IL-17A在卵巢癌中的表达水平及潜在机制的生物信息学分析[J].医学研究与战创伤救治(原医学研究生学报),2020,22(01):25.[doi:10.3969/j.issn.1672-271X.2020.01.006]
　CHENJuan,LIUChuan-li,CHENYan-si,et al.The expression level of IL-17A in ovarian cancer and the bioinformatics analysis of potential mechanism[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(06):25.[doi:10.3969/j.issn.1672-271X.2020.01.006]
[9]谢树红,黄惠娟,许玉黎,等.橄榄苦苷对体外卵巢癌SKOV3细胞增殖的影响[J].医学研究与战创伤救治(原医学研究生学报),2018,20(04):361.[doi:10.3969/j.issn.1672-271X.2018.04.008]
　XIE Shu-hong,HUANG Hui-juan,XU Yu-li,et al.Effects ofoleuropein on proliferation of ovarian cancer SKOV3 cells in vitro[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(06):361.[doi:10.3969/j.issn.1672-271X.2018.04.008]

备注/Memo

备注/Memo:
基金项目：全军医药卫生科研项目（14MS129）
更新日期/Last Update: 2018-11-20